Intermediate Uveitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-03-12
Clinical Trial Update: Ozurdex Monotherapy Trial [Phase 4]
The Phase 4 Ozurdex monotherapy trial for posterior uveitis, intermediate uveitis, and panuveitis has been withdrawn.